Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Canine study offers insights into treatment of human OCD
Doberman
CCD compulsions may include repetitive tail chasing, excessively grooming, and flank and blanket sucking.

Scientists identify genetic pathways that exacerbate the condition

Researchers have uncovered genetic pathways in Doberman pinschers that increase the severity of canine compulsive disorder.

Published in the International Journal of Applied Research, scientists hope the discovery will lead to better therapies for the treatment of obsessive compulsive disorder in humans.

Lead author Nicholas Dodman from Tufts University’s School of Veterinary Medicine, said: “Dogs naturally suffer complex diseases, including mental disorders that are similar to those in humans. Among those is canine compulsive disorder (CCD), the counterpart to human obsessive compulsive disorder (OCD).”

OCD is listed by the World Health Organisation as among the 20 most disabling diseases. Estimated to affect around one to three per cent of people, the condition is often characterised by time-consuming repetitive behaviours and distressing thoughts.

CCD compulsions may include repetitive tail chasing, excessively grooming, and flank and blanket sucking. However, therapies for compulsion disorder in dogs are not as effective as they could be.

To read more about the study visit vetcommunity.com (VC login required).


Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'